| Product Code: ETC8318692 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Overview |
3.1 Monaco Country Macro Economic Indicators |
3.2 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market - Industry Life Cycle |
3.4 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market - Porter's Five Forces |
3.5 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.9 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
4 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine |
4.2.2 Advancements in next-generation sequencing (NGS) technologies |
4.2.3 Growing prevalence of genetic disorders and cancer |
4.3 Market Restraints |
4.3.1 High cost associated with NGS testing |
4.3.2 Lack of skilled professionals in the field of genomics |
4.3.3 Regulatory challenges and data privacy concerns |
5 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Trends |
6 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market, By Types |
6.1 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Sequencing By Synthesis, 2021- 2031F |
6.1.4 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Ion Semiconductor Sequencing, 2021- 2031F |
6.1.5 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Single-Molecule Real-time Sequencing, 2021- 2031F |
6.1.6 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Nano Pore Sequencing, 2021- 2031F |
6.1.7 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Sequencing Technologies, 2021- 2031F |
6.2 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.2.3 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Drug Discovery, 2021- 2031F |
6.2.4 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Agricultural and Animal Research, 2021- 2031F |
6.2.5 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Applications, 2021- 2031F |
6.3 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Academic Institutes and Research Centres, 2021- 2031F |
6.3.3 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.3.4 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.3.5 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other End Users, 2021- 2031F |
6.4 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market, By Service |
6.4.1 Overview and Analysis |
6.4.2 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Human Genome Sequencing, 2021- 2031F |
6.4.3 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Single Cell Sequencing, 2021- 2031F |
6.4.4 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Microbial Genome-based Sequencing, 2021- 2031F |
6.4.5 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Gene Regulation Services, 2021- 2031F |
6.4.6 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Animal and Plant Sequencing, 2021- 2031F |
6.4.7 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Sequencing Services, 2021- 2031F |
6.5 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market, By Workflow |
6.5.1 Overview and Analysis |
6.5.2 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.5.3 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.5.4 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Data Analysis, 2021- 2031F |
7 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Import-Export Trade Statistics |
7.1 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Export to Major Countries |
7.2 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Imports from Major Countries |
8 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Key Performance Indicators |
8.1 Average turnaround time for NGS testing |
8.2 Rate of adoption of NGS testing in clinical settings |
8.3 Number of partnerships with healthcare providers for NGS testing services |
9 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market - Opportunity Assessment |
9.1 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Service, 2021 & 2031F |
9.5 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
10 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market - Competitive Landscape |
10.1 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Revenue Share, By Companies, 2024 |
10.2 Monaco Clinical Next-Generation Sequencing (NSG) Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here